✦ LIBER ✦

Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma: Interim follow-up of a multicenter phase II trial

✍ Scribed by John D Hainsworth

Book ID: 114481156
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 73 KB
Volume: 29
Category: Article
ISSN: 0093-7754
DOI: 10.1053/sonc.2002.30154

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bendamustine in Patients With Rituximab-

Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study

✍ Friedberg, J. W.; Cohen, P.; Chen, L.; Robinson, K. S.; Forero-Torres, A.; La Ca 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 118 KB

Phase II Multicenter Study of Bendamusti

Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma

✍ Robinson, K. S.; Williams, M. E.; van der Jagt, R. H.; Cohen, P.; Herst, J. A.; 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 119 KB

CHOP chemotherapy followed by Rituximab

CHOP chemotherapy followed by Rituximab consolidation as first line treatment in patients with follicular lymphoma. Long-term follow-up of a phase 2 trial

✍ Gerald Jäger; Franz Quehenberger; Werner Linkesch; Peter Neumeister 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB

90Yttrium-Ibritumomab-Tiuxetan as First-

90Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial

✍ Scholz, C. W.; Pinto, A.; Linkesch, W.; Linden, O.; Viardot, A.; Keller, U.; Hes 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 133 KB

Results of a phase II multicenter trial

Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

✍ Neubauer, Marcus A.; Garfield, David H.; Kuerfler, Paul R.; Raju, Robert N.; Lin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 98 KB

A multicenter phase II trial of etoposid

A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin’s lymphoma

✍ Sun Jin Sym; Dae Ho Lee; Hye Jin Kang; Seung Hyun Nam; Ho Young Kim; Seok Jin Ki 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 292 KB